Poor Outcomes for IgD Multiple Myeloma Patients Following High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Center Experience

Immunoglobulin (Ig) D multiple myeloma (MM) accounts for 2% of all MM cases and has been reported to be associated with poor prognosis compared with other MM subtypes. The aim of the present study was to compare the effects of high-dose melphalan treatment and autologous stem cell transplantation (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Chong, Yong Pil, Kim, Shin, Ko, Ok Bae, Koo, Ja Eun, Lee, Danbi, Park, Sang Hyoung, Park, Soo Jung, Lee, Daeho, Kim, Sang We, Suh, Cheolwon
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2008
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580008/
https://www.ncbi.nlm.nih.gov/pubmed/18955788
http://dx.doi.org/10.3346/jkms.2008.23.5.819

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2580008/
https://www.ncbi.nlm.nih.gov/pubmed/18955788
http://dx.doi.org/10.3346/jkms.2008.23.5.819

Ejemplares similares